Clinical phenotype, laboratory features and genotype of 35 patients with heritable dysfibrinogenaemia

British Journal of Haematology

Volumn 160, Issue 2, 2013, Pages 220-227

  Shapiro, Susan E ^a   Phillips, Emma ^b   Manning, Richard A ^a   Morse, Colin V ^c   Murden, Sherina L ^c   Laffan, Michael A ^a   Mumford, Andrew D ^c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Bleeding; Coagulation disorder; Dysfibrinogenaemia; Fibrin polymerization; Prothrombin time

Indexed keywords

BATROXOBIN; FIBRINOGEN; RECOMBINANT THROMBOPLASTIN; THROMBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; BLEEDING; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COAGULOMETER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DYSFIBRINOGENEMIA; FEMALE; FGN GENE; GENE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; LABORATORY DEVICE; LABORATORY TEST; MALE; NUCLEOTIDE SEQUENCE; PARTIAL THROMBOPLASTIN TIME; PHENOTYPE; PRIORITY JOURNAL; PROTHROMBIN TIME; SCHOOL CHILD; THROMBOSIS; UNITED KINGDOM;

ADOLESCENT; ADULT; AFIBRINOGENEMIA; AGED; ALLELES; BLOOD COAGULATION TESTS; CHILD; CROSS-SECTIONAL STUDIES; DNA MUTATIONAL ANALYSIS; ENGLAND; FEMALE; FIBRINOGENS, ABNORMAL; GENE FREQUENCY; GENOTYPE; HEMORRHAGE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PHENOTYPE; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84872271544     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12085     Document Type: Article

References (30)

1. Borrell, M., Gari, M., Coll, I., Vallve, C., Tirado, I., Soria, J.M., Sala, N., Munoz, C., Oliver, A., Garcia, A. & Fontcuberta, J. (1995) Abnormal polymerization and normal binding of plasminogen and t-PA in three new dysfibrinogenaemias: barcelona III and IV (gamma Arg 275->His) and Villajoyosa (gamma Arg 275->Cys). Blood Coagulation and Fibrinolysis, 6, 198-206.
2. Brennan, S.O., Hammonds, B. & George, P.M. (1995) Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val -> Asp). The Journal of Clinical Investigation, 96, 2854-2858.
3. Castaman, G., Ghiotto, R., Tosetto, A. & Rodeghiero, F. (2005) Bbeta 14 Arg -> Cys variant dysfibrinogen and its association with thrombosis. Journal of Thrombosis and Haemostasis, 3, 409-410.
4. Cunningham, M.T., Brandt, J.T., Laposata, M. & Olson, J.D. (2002) Laboratory diagnosis of dysfibrinogenemia. Archives of Pathology and Laboratory Medicine, 126, 499-505.
5. Everse, S.J., Spraggon, G., Veerapandian, L., Riley, M. & Doolittle, R.F. (1998) Crystal structure of fragment double-D from human fibrin with two different bound ligands. Biochemistry, 37, 8637-8642.
6. Hanss, M. & Biot, F. (2001) A database for human fibrinogen variants. Annals of the New York Academy of Sciences, 936, 89-90.
7. Hanss, M., Chevreaud, C., French, P., Negrier, C. & de Mazancourt, P. (2007) Clinical and biological features of 3 cases of hypofibrinogenemia associated with three different mutations (gamma Ala341Thr, Bbeta Tyr326Cys and Aalpha Asp496Asn). Thrombosis and Haemostasis, 98, 689-691.
8. Haverkate, F. & Samama, M. (1995) Familial dysfibrinogenemia and thrombophilia Report on a study of the SSC Subcommittee on Fibrinogen. Thrombosis and Haemostasis, 73, 151-161.
9. Hayes, T. (2002) Dysfibrinogenaemia and thrombosis. Archives of Pathology and Laboratory Medincine, 126, 1387-1390.
10. Hill, M. & Dolan, G. (2008) Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias. Haemophilia, 14, 889-897.
11. Lord, S.T. (2011) Molecular mechanisms affecting fibrin structure and stability. Arteriosclerosis, Thrombosis and Vascular Biology, 31, 494-499.
12. Ludlam, C.A., Pasi, K.J., Bolton-Maggs, P., Collins, P.W., Cumming, A.M., Dolan, G., Fryer, A., Harrington, C., Hill, F.G.H., Peake, I.R., Perry, D.J.Skirton, H. & Smith, M. (2005) A framework for genetic service provision for haemophilia and other inherited bleeding disorders. Haemophilia, 11, 145-163.
13. Mackie, I.J., Kitchen, S., Machin, S.J. & Lowe, G.D. (2003) Guidelines on fibrinogen assays. British Journal of Haematology, 121, 396-404.
14. Malkowski, M.G., Martin, P.D., Lord, S.T. & Edwards, B.F. (1997) Crystal structure of fibrinogen-Aalpha peptide 1-23 (F8Y) bound to bovine thrombin explains why the mutation of Phe-8 to tyrosine strongly inhibits normal cleavage at Arg-16. The Biochemical Journal, 326, 815-822.
15. Martin, P.D., Robertson, W., Turk, D., Huber, R., Bode, W. & Edwards, B.F. (1992) The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution. The Journal of Biological Chemistry, 267, 7911-7920.
16. Mathonnet, F., Peltier, J.Y., Roda, L., de Raucourt, E., D'Hailly, F., Tetegan, M., Catherine, N., Vinatier, I. & de Mazancourt, P. (2001) Three new cases of dysfibrinogenemia: poissy III, Saint-Germain I and Tahiti. Thrombosis Research, 103, 201-207.
17. Miesbach, W., Scharrer, I., Henschen, A., Neerman-Arbez, M., Spitzer, S. & Galanakis, D. (2010a) Inherited dysfibrinogenemia: clinical phenotypes associated with five different fibrinogen structure defects. Blood Coagulation and Fibrinolysis, 21, 35-40.
18. Miesbach, W., Schenk, J., Alesci, S. & Lindhoff-Last, E. (2010b) Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia. Thrombosis Research, 126, 428-433.
19. Morris, T.A., Marsh, J.J., Chiles, P.G., Magana, M.M., Liang, N.C., Soler, X., Desantis, D.J., Ngo, D. & Woods, V.L. Jr. (2009) High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood, 114, 1929-1936.
20. Mosesson, M.W. (2005) Fibrinogen and fibrin structure and functions. Journal of Thrombosis and Haemostasis, 3, 1894-1904.
21. Niwa, K., Mimuro, J., Miyata, M., Sugo, T., Ohmori, T., Madoiwa, S., Tei, C. & Sakata, Y. (2008) Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule. Thrombosis Research, 121, 773-780.
22. Pratt, K.P., Cote, H.C., Chung, D.W., Stenkamp, R.E. & Davie, E.W. (1997) The primary fibrin polymerization pocket: three-dimensional structure of a 30-kDa C-terminal gamma chain fragment complexed with the peptide Gly-Pro-Arg-Pro. Proceedings of the National Academy of Sciences of the United States of America, 94, 7176-7181.
23. Roberts, H.R., Stinchcombe, T.E. & Gabriel, D.A. (2001) The dysfibrinogenaemias. British Journal of Haematology, 114, 249-257.
24. Rodeghiero, F., Tosetto, A., Abshire, T., Arnold, D.M., Coller, B., James, P., Neunert, C. & Lillicrap, D. (2010) ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. Journal of Thrombosis and Haemostasis, 8, 2063-2065.
25. Spraggon, G., Everse, S.J. & Doolittle, R.F. (1997) Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature, 389, 455-462.
26. Sugo, T., Endo, H., Matsuda, M., Ohmori, T., Madoiwa, S., Mimuro, J. & Sakata, Y. (2006) A classification of the fibrin network structures formed from the hereditary dysfibrinogens. Journal of Thrombosis and Haemostasis, 4, 1738-1746.
27. Tosetto, A., Castaman, G., Plug, I., Rodeghiero, F. & Eikenboom, J. (2011) Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation. Journal of Thrombosis and Haemostasis, 9, 1143-1148.
28. UK NEQAS. (2011) U.K. National External Quality Assessment Scheme for Blood Coagulation Report on Survey 186. http://www.ukneqasbc.org/documents/S186%20report(3).pdf
29. Wada, Y., Niwa, K., Maekawa, H., Asakura, S., Sugo, T., Nakanishi, M., Auerswald, G., Popp, M. & Matsuda, M. (1993) A new type of congenital dysfibrinogen, fibrinogen Bremen, with an A alpha Gly-17 to Val substitution associated with hemorrhagic diathesis and delayed wound healing. Thrombosis and Haemostasis, 70, 397-403.
30. Weisel, J.W., Veklich, Y. & Gorkun, O. (1993) The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. Journal of Molecular Biology, 232, 285-297.